Session Chair Profile
Biography
Kristine Crews is a clinical scientist in the field of pharmacokinetics and pharmacogenomics. She serves as the Residency Director of the Clinical Pharmacogenomics program at St. Jude Children's Research Hospital. With degrees from Rutgers University and extensive training including a residency and a fellowship in Clinical Pharmacokinetics Pharmacodynamics and Drug Development, Dr. Crews focuses her research on the clinical implementation of pharmacogenomics to individualize treatment regimens, particularly in pediatric oncology. She is a founding member of the Clinical Pharmacogenetics Implementation Consortium and serves as an author for CPIC guidelines. She is a Fellow of the American College of Clinical Pharmacy and has received numerous awards for her contributions to the clinical pharmacology literature.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristin Wiisanen, Rosalind Franklin University
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jason Roos, ARPA-H
- Jennifer Wick, The Christ Hospital Health Network
- What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA